tiprankstipranks
Aurinia says PTAB has terminated Inter Partes review
The Fly

Aurinia says PTAB has terminated Inter Partes review

Aurinia Pharmaceuticals announced that the Patent Trial and Appeal Board of the United States’ Patent and Trademark Office has terminated the Inter Partes Review it had instituted with respect to Aurinia’s U.S. Patent No. 10,286,036.

Published first on TheFly

See Insiders’ Hot Stocks on TipRanks >>

Read More on AUPH:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles